Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2026-01-29 @ 8:45 AM
Study NCT ID:
NCT02225418
Status:
WITHDRAWN
Last Update Posted:
2015-07-22
First Post:
2014-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy
Sponsor:
Jens Borglum Neimann
Organization:
Study Overview
Official Title:
Ultrasoundguided Transmuscular Quadratus Lumborum Block After Elective Laparoscopic Cholecystectomy. A Prospective, Randomized Clinical Trial.
Status:
WITHDRAWN
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Change of jobs
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TQL
Brief Summary:
The TQL block may prove a valuable method for treating postoperative pain following scopic removal of the gall bladder.
The trial will compare active TQL block versus placebo TQL block after said operation.
The hypothesis is that active TQL block significantly will reduce postoperative pain following scopic removal of the gall bladder compared with placebo TQL block.
The trial will compare active TQL block versus placebo TQL block after said operation.
The hypothesis is that active TQL block significantly will reduce postoperative pain following scopic removal of the gall bladder compared with placebo TQL block.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2013-001364-30 | EUDRACT_NUMBER | None | View |